Billiontoone (NASDAQ:BLLN) Trading Up 7.7% – Here’s What Happened

Shares of Billiontoone, Inc. (NASDAQ:BLLN) were up 7.7% on Monday . The stock traded as high as $88.35 and last traded at $88.9690. Approximately 299,183 shares changed hands during trading, a decline of 22% from the average daily volume of 383,568 shares. The stock had previously closed at $82.63.

Analyst Ratings Changes

A number of research firms have issued reports on BLLN. BTIG Research decreased their target price on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday. Guggenheim increased their price objective on shares of Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Wells Fargo & Company decreased their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 5th. Finally, Wall Street Zen upgraded Billiontoone from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Six research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $125.29.

Billiontoone Trading Up 4.6%

The business has a 50-day moving average of $79.84. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. The firm has a market cap of $3.97 billion and a price-to-earnings ratio of 157.09.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. The company’s quarterly revenue was up 83.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.39) EPS. Analysts predict that Billiontoone, Inc. will post 0.93 EPS for the current year.

Institutional Investors Weigh In On Billiontoone

Several institutional investors and hedge funds have recently made changes to their positions in the business. Rossby Financial LCC bought a new stake in Billiontoone in the fourth quarter worth approximately $25,000. Wells Fargo & Company MN acquired a new stake in shares of Billiontoone during the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC bought a new stake in shares of Billiontoone in the 4th quarter valued at $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Billiontoone during the 4th quarter valued at $82,000. Finally, Renaissance Capital LLC acquired a new position in shares of Billiontoone during the 4th quarter valued at $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.